Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lineage Cell Therapeutics (LCTX) Minority Interest: 2010-2025

Historic Minority Interest for Lineage Cell Therapeutics (LCTX) over the last 15 years, with Sep 2025 value amounting to -$1.2 million.

  • Lineage Cell Therapeutics' Minority Interest rose 10.63% to -$1.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.2 million, marking a year-over-year increase of 10.63%. This contributed to the annual value of -$1.4 million for FY2024, which is 1.93% up from last year.
  • Lineage Cell Therapeutics' Minority Interest amounted to -$1.2 million in Q3 2025, which was up 2.28% from -$1.3 million recorded in Q2 2025.
  • In the past 5 years, Lineage Cell Therapeutics' Minority Interest registered a high of -$1.1 million during Q1 2021, and its lowest value of -$1.5 million during Q3 2023.
  • In the last 3 years, Lineage Cell Therapeutics' Minority Interest had a median value of -$1.4 million in 2023 and averaged -$1.4 million.
  • As far as peak fluctuations go, Lineage Cell Therapeutics' Minority Interest surged by 36.59% in 2021, and later decreased by 24.22% in 2022.
  • Over the past 5 years, Lineage Cell Therapeutics' Minority Interest (Quarterly) stood at -$1.3 million in 2021, then fell by 6.05% to -$1.4 million in 2022, then grew by 0.50% to -$1.4 million in 2023, then rose by 1.93% to -$1.4 million in 2024, then grew by 10.63% to -$1.2 million in 2025.
  • Its Minority Interest stands at -$1.2 million for Q3 2025, versus -$1.3 million for Q2 2025 and -$1.4 million for Q1 2025.